Harry Hendrikse
Amsterdam University Medical Centers, University of Amsterdam
Papers
2
Total Citations
47
H-Index
2
About
Harry Hendrikse is a leading researcher in the field of oncological imaging, with a primary focus on improving the detection and prognostication of prostate cancer. His work centers on the integration of advanced imaging modalities, specifically prostate-specific membrane antigen (PSMA) positron emission tomography (PET) and multiparametric magnetic resonance imaging (mpMRI), to enhance clinical decision-making. Hendrikse’s major contributions include the landmark ProStaPET study, which prospectively demonstrated the superior accuracy of [18F]DCFPyL PSMA-PET/MRI over mpMRI alone in detecting clinically significant prostate cancer, using radical prostatectomy histopathology as the gold standard. This work, cited 27 times, has helped solidify the role of hybrid imaging in surgical planning. Additionally, his research on predicting early oncological outcomes in intermediate- and high-risk patients has identified key imaging biomarkers that outperform conventional variables, garnering 20 citations. By bridging the gap between radiology and urology, Hendrikse’s findings are directly shaping more precise, personalized treatment pathways for men with prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2